Warner Bros. Discovery heads into the back half of September with one striking tension: the stock has rallied 10% on the week to $30.83, yet insiders have been selling aggressively into every uptick.
The insider activity is the clearest story here. In the 90 days through September 14, net insider selling totalled more than $141 million across open-market disposals — a concentrated pattern rather than a handful of isolated trades. Director Kenneth Lowe filed two separate sales in early September worth a combined $11.3 million. Chief People Officer Amy Girdwood sold $7.3 million of stock on September 9. Director Anton Levy offloaded $9.7 million on September 3. The Chief Accounting Officer added another $819,000 on September 14. None of these transactions were made under pre-arranged 10b5-1 plans, which makes them discretionary. CEO David Zaslav's August sale of 195,000 shares for $5.5 million was under a 10b5-1 plan — a distinction worth noting, but it adds to the volume rather than offsetting it. When this many executives sell into a rally, the signal is harder to dismiss.
Options positioning amplifies the caution. The put/call ratio has climbed to 2.58, running nearly two standard deviations above its 20-day average of 2.42 — close to its 52-week high of 2.86. That level of put-heavy positioning suggests options traders are more interested in hedging or pressing the downside than participating in the rally. The ratio was materially lower through mid-August, around 1.8, before jumping sharply in the last four weeks. The shift in options sentiment coincides almost exactly with the insider selling cluster.
Short positioning tells a far less dramatic story. Short interest is a modest 2.8% of the free float — well below any threshold that would characterise WBD as a heavily shorted stock. It has edged up about 0.8% on the week and is down roughly 4% over the past month, drifting rather than building. The lending market is completely unencumbered: availability is vast at nearly 6,900% of outstanding short interest, meaning there is no scarcity of borrow whatsoever. Cost to borrow has halved over the past week to just 0.25%. The ORTEX short score of 33 is below the midpoint of its range and has been easing since mid-September. None of this points to meaningful short-side conviction.
The Street is roughly neutral, which fits. Morgan Stanley raised its price target to $31 — effectively in line with the current price of $30.83 — while keeping an Equal-Weight rating, filed just this week. Barclays reinstated coverage with an Equal-Weight and a $29 target last week. The consensus mean target of $30.17 implies the stock is already trading above where the average analyst thought it would be. The bull case — HBO Max and Discovery+ bundling, the Paramount Skydance deal as a value catalyst, international linear monetisation — is well-known. The bear case centres on cord-cutting, advertiser competition, and a balance sheet that still carries meaningful leverage. EPS momentum factor scores rank in the bottom decile, and the stock is loss-making on a trailing basis (PE is deeply negative), though EV/EBITDA of 13x is more workable. An activist filer, A/NPP Diversified Holdings, holds a Schedule 13D position — filed in July 2025 at 3.97% of shares — though that disclosure is as-last-reported and stakes around the 5% threshold can shift without a new filing.
The next scheduled earnings release is November 6. The prior two prints each produced single-day moves of roughly 1.8% and 3.1%, with five-day drifts of 6% in both cases — both to the upside. With the stock already at analyst mean-target levels and insiders consistently selling into the rally, how management frames the streaming subscriber trajectory and the balance sheet path at that November print becomes the session's central question.
See the live data behind this article on ORTEX.
Open WBD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
